On admission the patient was afebrile, her pulse was 107 beats/min and irregular, her blood pressure was 180/100 mm Hg. An apical systolic murmur was heard. She was lethargic but responded to verbal stimuli. The right pupil was slightly wider than the left, both equally reactive to light. Right sided hemiparesis and an extensor plantar response were noted. Brain CT obtained 48 hours after her admission showed a hypodense lesion within the left cerebellar hemisphere, with surrounding oedema, consistent with a recent stroke in the territory of the left anterior inferior cerebellar artery. On the fourth day in hospital she became somnolent, responding only to painful stimuli. Ptosis and proptosis of the right eye with pronounced chemosis appeared. Oculocephalic response was normal on the left, but she had seventh and partial third nerve palsies on the right. The pupil was dilated and unresponsive to light. Repeated CT showed a large cerebellar infarction with massive oedema, compression of the fourth ventricle, and hydrocephalus (figure). A continuous pressure controlled ventricular drainage system was inserted, with prompt improvement in the patient's alertness and regression of the ocular findings within 24 hours. Her subsequent hospital course was complicated by staphylococcocal septicaemia and she died on the 12th day after her admission.
Unilateral proptosis is almost invariably the result of acute or chronic disorders within or around the orbit.' Rarely, it is caused by chronic increase in intracranial pressure.2 3 We are unaware of a previous report of proptosis as the consequence of a posterior fossa stroke complicated by acute hydrocephalus. Nor has proptosis been associated with other causes of acutely increased intracranial pressure. The postulated mechanism by which intracranial hypertension may lead to exophthalmus is transmission of increased pressure to the orbital veins, resulting in orbital tissue oedema. Proptosis caused by this mechanism is usually symmetric but due to the highly variable drainage of the cavernous sinuses it could be unilateral. (table) . Although the immediate memory span was normal, he was unable to recall any previously acquired explicit information, independent of the modality of presentation. Both in recall and recognition tasks, he denied any familiarity with the items and had a high rate of false positives in forced choice recognition tasks. An autobiographical interview and a test probing knowledge about Swiss politicians disclosed a temporally graded retrograde amnesia extending 10 to 15 years backwards. Semantic memory was normal, as evidenced by normal naming and verbal fluency. Motor learning in a mirror drawing task was normal.
Brain MRI was performed three times. In the initial MRI 10 days after onset, both hippocampi seemed discretely swollen with blurring of the cortical structure. In the MRIs after three and 10 months, both hippocampi appeared considerably smaller than in the initial scan (figure) . No additional lesions were found; in particular, there was no indication of small hemispheric or thalamic vascular lesions.
Transcranial and carotid Doppler ultrasound examination and echocardiography were normal. Thrombocytopenia persisted (15 to 31 x 109/1). Haemoglobin and leucocyte count, renal function, and liver enzymes were normal. A bone marrow biopsy showed normal haematopoiesis.
Antinuclear
(1:400), anti-dsDNA, and anti-ssDNA antibodies were raised. No antibodies were detected against ENA-Sm, phospholipid, thrombocytes (anti-GPIIb/IIIa and antiGPIb/IX), or neurotrophic viruses. No antineuronal antibodies were found (sought after five months when antinuclear antibodies were no longer detectable). Complement factor C4 was slightly decreased (135 mg/l), C3 was normal. A skin biopsy contained deposits of IgG, IgM, and C3 along the basal membrane. These findings were consistent with a diagnosis of systemic lupus erythematosus according to the 1982 American Rheumatism Association criteria.
The patient was treated with prednisone (75 mg daily for 12 weeks), cyclophosphamide (150 mg daily for 10 weeks), and
